BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2004
View Archived Issues
Novel small molecule with thrombopoietin mimetic activity
Read More
Potent PARP inhibitor improves cardiac and endothelial dysfunction
Read More
Bivalent mu-kappa opioid receptor ligand attenuates morphine tolerance
Read More
Combined immunostimulatory treatment enhances antitumor activity in vivo
Read More
New approach to cardiovascular diseases by targeting NFkappaB
Read More
Curcuma longa shows cardioprotective effects in vivo
Read More
Yentreve approved in E.U. for stress urinary incontinence
Read More
King and Palatin to jointly develop, commercialize PT-141
Read More
Genelabs completes Prestara study
Read More
AMG-162 pivotal study triggers milestone payment to Abgenix
Read More
Swiss approval for Femara as extended adjuvant treatment
Read More
New phase II study for HuMax-CD4 in non-cutaneous T-cell lymphoma
Read More
Three series of chemokine CCR5 modulators claimed by AstraZeneca
Read More
Selective neutral endopeptidase inhibitors reported by Pfizer scientists
Read More
Novel oxazolidinone-based antibacterial agents under study at AstraZeneca
Read More
Alpharma presents new 10-modified erythromycins and their use as antibacterial agents
Read More
New HSP90 inhibitors and their use in cancer and other disorders
Read More
New TACE inhibitors and their use covered by Vertex patent
Read More
FDA and Genentech issue warning on Avastin
Read More
Cangene plans new anthrax project
Read More
Medinox and PUMC to develop NOX-100 in China and South Korea
Read More
Positive opinion for reimbursement of Advate in France
Read More
MorphoSys and Boehringer Ingelheim initiate new antibody program
Read More
European approval for higher dosage of candesartan cilexetil
Read More
Amgen completes acquisition of Tularik
Read More
Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH
Read More
Discovery of potent himbacine-based thrombin receptor antagonist
Read More
Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy
Read More
Improved histamine H3 antagonists/inverse agonists presented by Abbott
Read More